University of California, San Francisco, San Francisco, CA.
Touro University California, Vallejo, CA, USA.
Am J Health Syst Pharm. 2022 Nov 22;79(23):2134-2140. doi: 10.1093/ajhp/zxac243.
To track and analyze the growth of 12 Board of Pharmacy Specialties (BPS) specialties from 2008 to 2020 and, subject to criteria, to project specialty numbers through 2025. The analysis considered residency data and Bureau of Labor Statistics projections.
BPS data were used to determine numeric growth, growth rates, and trends for 12 BPS specialties from 2008 to 2020. Specialties begun after 2008 were analyzed from their start date. For specialties with more than 2 data points and coefficients of determination greater than 0.80, we calculated projections through 2025. We also estimated the percentage of BPS-certified pharmacists with postgraduate year 1 training.
BPS-certified pharmacists grew in number from 3,004 (2008) to 41,802 (2020), an over 13-fold increase. Currently, 4 of the 5 largest specialties (pharmacotherapy, ambulatory care, oncology, and critical care) continue to grow at a fast rate. Pharmacotherapy experienced the largest numeric growth (20,624) despite the ongoing introduction of new specialties. Critical care and infectious diseases had the highest growth rates (both 32%). We were able to make projections for 10 of 12 specialties, with greater than 62,000 certifications projected by 2025. Growth to these projected levels will require more residencies and more certification preparation opportunities. Residency-trained BPS specialists currently constitute slightly less than 50% of the BPS-certified population.
Specialization in the pharmacy profession is growing at a rapid pace. As more clinical privileges are approved, the demand for more specialized pharmacists will likely continue to increase. Data from this study document the growth of the pharmacy specialty workforce. The data and analysis can be used to estimate potential pharmacist contributions across the healthcare spectrum in clinical areas where BPS-certified pharmacists practice.
跟踪和分析 2008 年至 2020 年 12 个药学专业委员会（BPS）专业的发展情况，并根据标准预测到 2025 年的专业数量。该分析考虑了住院医师数据和劳工统计局的预测。
使用 BPS 数据确定了 2008 年至 2020 年 12 个 BPS 专业的数量增长、增长率和趋势。对 2008 年后开始的专业进行了分析。对于有 2 个以上数据点和决定系数大于 0.80 的专业，我们计算了到 2025 年的预测。我们还估计了具有研究生 1 年培训的 BPS 认证药师的百分比。
BPS 认证药师的数量从 2008 年的 3004 人增加到 2020 年的 41802 人，增长了 13 倍以上。目前，5 个最大的专业（药物治疗学、门诊护理、肿瘤学和重症监护）中的 4 个仍在快速增长。尽管新专业不断推出，但药物治疗学的数量增长最大（20624 人）。重症监护和传染病的增长率最高（均为 32%）。我们能够对 12 个专业中的 10 个进行预测，到 2025 年预计将有超过 62000 个认证。要达到这些预测水平，需要更多的住院医师和更多的认证准备机会。经过住院医师培训的 BPS 专家目前略低于 BPS 认证人群的 50%。
药学专业的专业化正在迅速发展。随着更多的临床权限获得批准，对更专业的药师的需求可能会继续增加。本研究的数据记录了药学专业人员队伍的增长。这些数据和分析可用于估计在 BPS 认证药师执业的临床领域中，整个医疗保健领域中药师的潜在贡献。
